Cargando…
Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
INTRODUCTION: H.P. ACTHar gel is a preparation of melanocortin peptides that has been used to treat resistant forms of nephrotic syndrome. To determine whether combination therapy with ACTHar gel and tacrolimus reduces proteinuria and stabilizes renal function, we conducted a prospective, open-label...
Autores principales: | Tumlin, James, Galphin, Claude, Santos, Raul, Rovin, Brad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733765/ https://www.ncbi.nlm.nih.gov/pubmed/29270498 http://dx.doi.org/10.1016/j.ekir.2017.05.015 |
Ejemplares similares
-
Membranous glomerulopathy and treatment with Acthar®: a case study
por: Watson, Myra June
Publicado: (2013) -
A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis
por: Iguchi, Akira, et al.
Publicado: (2013) -
Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
por: Tumlin, J. A., et al.
Publicado: (2013) -
COVID-19–Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis
por: Magoon, Sandeep, et al.
Publicado: (2020) -
Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases
por: Markell, Mariana, et al.
Publicado: (2019)